Lyka Labs is trading -2.16% lower at Rs 122.25 as compared to its last closing price. Lyka Labs has been trading in the price range of 125.25 & 118.55. Lyka Labs has given -20.99% in this year & -10.70% in the last 5 days. Lyka Labs has TTM P/E ratio 138.12 as compared to the sector P/E of 25.53.The company posted a net profit of 2.71 Crores in its last quarter.Listed peers of Lyka Labs include Kilitch Drugs India (-2.95%), Zim Laboratories (-3.98%), Lyka Labs (-2.16%).The Mutual Fund holding in Lyka Labs was at 0.01% in 31 Dec 2024. The MF holding has decreased from the last quarter. The FII holding in Lyka Labs was at 0.15% in 31 Dec 2024. The FII holding has decreased from the last quarter.
Updated on Feb 14, 2025, 09:32 PM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Kilitch Drugs India | Bearish | 306.05 | -2.95 | 492.36 | 33.66 | 2.98 | - | - |
Zim Laboratories | Bearish | 93.00 | -3.98 | 452.88 | 30.13 | 2.18 | - | 16.15 |
Lyka Labs | Bearish | 122.25 | -2.16 | 434.10 | - | 6.79 | - | 64.80 |
Venus Remedies | Bearish | 316.20 | 0.05 | 421.28 | 16.92 | 0.99 | - | 7.93 |
Jenburkt Pharmaceuticals | Bearish | 1,014.80 | -7.35 | 447.86 | 18.18 | 3.26 | 1.43 | - |
Meeting Date | Purpose |
---|---|
2025-02-04 | Quarterly Results |
2024-11-12 | Quarterly Results |
2024-10-11 | Others |
2024-08-09 | Quarterly Results |
2024-05-21 | Audited Results & Others |
Lyka Labs is trading at 122.25 as on Fri Feb 14 2025 09:58:17. This is -2.16% lower as compared to its previous closing price of 124.95.
The market capitalization of Lyka Labs is 434.10 Cr as on Fri Feb 14 2025 09:58:17.
The 52 wk high for Lyka Labs is 175.95 whereas the 52 wk low is 99.95
Lyka Labs can be analyzed on the following key metrics -
Lyka Labs reported a net profit of -2.49 Cr in 2024.
The Mutual Fund Shareholding was 0.01% at the end of 31 Dec 2024.